GenomeWeb Index Rises in March as Some Firms Post Positive Q4 Results | GenomeWeb

NEW YORK (GenomeWeb) – The GenomeWeb Index rose 6.4 percent in March, as the majority of the stocks posted gains, some significant.

The GenomeWeb Index performed roughly in line with the Dow Jones Industrial Average, which gained 7.1 percent during the month, and the Nasdaq, which gained 6.8 percent. It significantly outperformed the Nasdaq Biotechnology Index, which finished the month 2.5 percent higher.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.